About
ProSciento is a global clinical research organization, exclusively focused on drug and device development programs for diabetes, NASH, obesity and related metabolic diseases. Building on two decades of experience and more than 425 completed metabolic clinical trials, ProSciento provides customized clinical research services for multinational clinical trial programs. Our scalable R&D service model incorporates therapeutic expertise, advanced methodologies, patient access strategies, and global operational excellence to provide our clients an unique advantage in today’s rapidly evolving landscape of metabolic drug and device development.
Recommended Materials
Fact Sheets
Specialized Expertise to Drive Advances in Diabetes Drug and Device Development
Fact Sheets
Clinical Research Strategies to Drive Advances in Obesity Drug Development
Related Solutions
Our Metabolic Focus
